PCN70 Cost Effectiveness Analysis of Pembrolizumab in the Treatment of Adults with STAGE III Melanoma and Lymph Node Involvement WHO Have Undergone Complete Resection - the Greek Setting
Abstract
Authors
N. Yfantopoulos E. Dalakaki M. Papageorgiou A. Karokis